Gaelle Bussac-Rousseau
Creteil, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.
Journal: Translational lung cancer research
Published: March 27, 2026
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: May 06, 2025
Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS Study.
Journal: Targeted oncology
Published: February 03, 2025
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 26, 2024
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case report.
Journal: Translational lung cancer research
Published: September 12, 2024
Evaluation of local anesthesia with buffered Xylocaine in pleural procedures: The DOULAPLUX study
Journal: Revue des maladies respiratoires
Published: May 27, 2024
Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case report.
Journal: Translational lung cancer research
Published: April 30, 2024
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 20, 2024
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Journal: Targeted oncology
Published: October 21, 2023
Erratum to "When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study" [Bull. Cancer 109 (2022) 916-24].
Journal: Bulletin du cancer
Published: February 22, 2023
Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study.
Journal: Journal of cancer research and therapeutics
Published: December 13, 2022
ICU admission for solid cancer patients treated with immune checkpoint inhibitors.
Journal: Annals of intensive care
Published: October 10, 2022
Last Updated: 09/26/2026